1-13 of 13
idelalisib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.
https://doi.org/10.1182/hematology.2019000032
Published: 2019
Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.
https://doi.org/10.1182/hematology.2019000367
Published: 2019
Journal Articles

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Gianluca Gaidano, Davide Rossi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 329–337.
https://doi.org/10.1182/asheducation-2017.1.329
Published: 2017
Journal Articles

How should we sequence and combine novel therapies in CLL?

Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 346–353.
https://doi.org/10.1182/asheducation-2017.1.346
Published: 2017
Journal Articles

Safety profiles of novel agent therapies in CLL

Inhye E. Ahn, Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 354–357.
https://doi.org/10.1182/asheducation-2017.1.354
Published: 2017
Journal Articles

Sequencing of chronic lymphocytic leukemia therapies

Jacqueline C. Barrientos
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 128–136.
https://doi.org/10.1182/asheducation-2016.1.128
Published: 2016
Journal Articles

Novel agents in chronic lymphocytic leukemia

Nicole Lamanna, Susan O’Brien
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 137–145.
https://doi.org/10.1182/asheducation-2016.1.137
Published: 2016
Journal Articles

Patterns of resistance to B cell–receptor pathway antagonists in chronic lymphocytic leukemia and strategies for management

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 355–360.
https://doi.org/10.1182/asheducation-2015.1.355
Published: 2015
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

Management of prolymphocytic leukemia

Claire Dearden
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 361–367.
https://doi.org/10.1182/asheducation-2015.1.361
Published: 2015
Journal Articles

B-cell receptor pathway modulators in NHL

Kristie A. Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 82–91.
https://doi.org/10.1182/asheducation-2015.1.82
Published: 2015
Journal Articles

BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma

Adrian Wiestner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 125–134.
https://doi.org/10.1182/asheducation-2014.1.125
Published: 2014
Journal Articles

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

Adrian Wiestner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 88–96.
https://doi.org/10.1182/asheducation.V2012.1.88.3801172
Published: 2012